Cargando…
Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens
INTRODUCTION: Depression is a co-morbidity of clinical significance in HIV-positive patients with an estimated prevalence of more than 20%. Sex and gender-related differences in depression are well described in HIV-negative populations, demonstrating that more women are being affected. So far little...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International AIDS Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225293/ https://www.ncbi.nlm.nih.gov/pubmed/25397466 http://dx.doi.org/10.7448/IAS.17.4.19720 |
_version_ | 1782343476335083520 |
---|---|
author | Philippe Küpper-Tetzel, Claus Göpel, Siri Khaykin, Pavel Wolf, Timo Stephan, Christoph Herrmann, Eva Brodt, Hans-Reinhard Haberl, Annette |
author_facet | Philippe Küpper-Tetzel, Claus Göpel, Siri Khaykin, Pavel Wolf, Timo Stephan, Christoph Herrmann, Eva Brodt, Hans-Reinhard Haberl, Annette |
author_sort | Philippe Küpper-Tetzel, Claus |
collection | PubMed |
description | INTRODUCTION: Depression is a co-morbidity of clinical significance in HIV-positive patients with an estimated prevalence of more than 20%. Sex and gender-related differences in depression are well described in HIV-negative populations, demonstrating that more women are being affected. So far little is known about frequency and characteristics of depression in HIV-positive men and women. MATERIALS AND METHODS: Primary objective of our prospective epidemiological study was the evaluation of the Beck score for depression in male and female patients of the Frankfurt HIV Cohort. The Beck Depression Inventory (BDI-II) is a self-report symptom inventory made up of 21 questions, each with 4 possible answers, correlating with a certain point value. Interpretation: score 14–19: mild depression; score 20–28: moderate depression; score ≥29: severe depression. Secondary objectives of the analysis were factors that might possibly influence the disposition for depression in HIV-positive patients, e.g. age, antiretroviral treatment history, co-morbidities and socioeconomic status. RESULTS: Between January and October 2013, 348 patients were enrolled in the study, 161 women and 187 men of the Frankfurt HIV Cohort, who had a routine appointment at the HIV-Center of the University Clinic Frankfurt. The mean age of all study participants was 45 years (range 22–80). The majority of patients were on antiretroviral therapy (91%) at study entrance. The median BDI-II score in all patients was 8 (0–49); in female patients 10 (0–42), in male patients 6 (0–49), respectively (Table 1). Significant more women than men showed a score for moderate depression (p=0.006). Factors associated with a BDI-II score ≥20 in women were older age (>45 years), living alone, unemployment and the number of prior changes in antiretroviral therapy. CONCLUSIONS: Depression in people living with HIV shows sex and gender-related differences that might also influence antiretroviral treatment strategies. HIV specialists should be aware of these gender-specific aspects and consider routine screening for depression especially in female patients of older age or those with multiple therapy changes in history. |
format | Online Article Text |
id | pubmed-4225293 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | International AIDS Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-42252932014-11-12 Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens Philippe Küpper-Tetzel, Claus Göpel, Siri Khaykin, Pavel Wolf, Timo Stephan, Christoph Herrmann, Eva Brodt, Hans-Reinhard Haberl, Annette J Int AIDS Soc Poster Sessions – Abstract P188 INTRODUCTION: Depression is a co-morbidity of clinical significance in HIV-positive patients with an estimated prevalence of more than 20%. Sex and gender-related differences in depression are well described in HIV-negative populations, demonstrating that more women are being affected. So far little is known about frequency and characteristics of depression in HIV-positive men and women. MATERIALS AND METHODS: Primary objective of our prospective epidemiological study was the evaluation of the Beck score for depression in male and female patients of the Frankfurt HIV Cohort. The Beck Depression Inventory (BDI-II) is a self-report symptom inventory made up of 21 questions, each with 4 possible answers, correlating with a certain point value. Interpretation: score 14–19: mild depression; score 20–28: moderate depression; score ≥29: severe depression. Secondary objectives of the analysis were factors that might possibly influence the disposition for depression in HIV-positive patients, e.g. age, antiretroviral treatment history, co-morbidities and socioeconomic status. RESULTS: Between January and October 2013, 348 patients were enrolled in the study, 161 women and 187 men of the Frankfurt HIV Cohort, who had a routine appointment at the HIV-Center of the University Clinic Frankfurt. The mean age of all study participants was 45 years (range 22–80). The majority of patients were on antiretroviral therapy (91%) at study entrance. The median BDI-II score in all patients was 8 (0–49); in female patients 10 (0–42), in male patients 6 (0–49), respectively (Table 1). Significant more women than men showed a score for moderate depression (p=0.006). Factors associated with a BDI-II score ≥20 in women were older age (>45 years), living alone, unemployment and the number of prior changes in antiretroviral therapy. CONCLUSIONS: Depression in people living with HIV shows sex and gender-related differences that might also influence antiretroviral treatment strategies. HIV specialists should be aware of these gender-specific aspects and consider routine screening for depression especially in female patients of older age or those with multiple therapy changes in history. International AIDS Society 2014-11-02 /pmc/articles/PMC4225293/ /pubmed/25397466 http://dx.doi.org/10.7448/IAS.17.4.19720 Text en © 2014 Philippe Küpper-Tetzel C et al; licensee International AIDS Society http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster Sessions – Abstract P188 Philippe Küpper-Tetzel, Claus Göpel, Siri Khaykin, Pavel Wolf, Timo Stephan, Christoph Herrmann, Eva Brodt, Hans-Reinhard Haberl, Annette Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens |
title |
Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens |
title_full |
Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens |
title_fullStr |
Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens |
title_full_unstemmed |
Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens |
title_short |
Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens |
title_sort | depression in hiv-positive women is associated with changes in antiretroviral treatment regimens |
topic | Poster Sessions – Abstract P188 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225293/ https://www.ncbi.nlm.nih.gov/pubmed/25397466 http://dx.doi.org/10.7448/IAS.17.4.19720 |
work_keys_str_mv | AT philippekuppertetzelclaus depressioninhivpositivewomenisassociatedwithchangesinantiretroviraltreatmentregimens AT gopelsiri depressioninhivpositivewomenisassociatedwithchangesinantiretroviraltreatmentregimens AT khaykinpavel depressioninhivpositivewomenisassociatedwithchangesinantiretroviraltreatmentregimens AT wolftimo depressioninhivpositivewomenisassociatedwithchangesinantiretroviraltreatmentregimens AT stephanchristoph depressioninhivpositivewomenisassociatedwithchangesinantiretroviraltreatmentregimens AT herrmanneva depressioninhivpositivewomenisassociatedwithchangesinantiretroviraltreatmentregimens AT brodthansreinhard depressioninhivpositivewomenisassociatedwithchangesinantiretroviraltreatmentregimens AT haberlannette depressioninhivpositivewomenisassociatedwithchangesinantiretroviraltreatmentregimens |